|
|
Volumn 10, Issue 6, 2002, Pages 2031-2049
|
|
3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agents
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
9 CHLORO 15 CYCLOHEXYL 11,15 DIHYDROXY 3 OXA 16,17,18,19,20 PENTANOR 5 PROSTENOIC ACID;
9 CHLORO 15 CYCLOHEXYL 11,15 DIHYDROXY 3 OXA 16,17,18,19,20 PENTANOR 5 PROSTENOIC ACID ISOPROPYL ESTER;
9BETA CHLORO 15 CYCLOHEXYL 9 DEOXY 16,17,18,19,20 PENTANOR 3 OXAPROSTAGLANDIN F2 ALPHA;
AL 6556;
AL 6598;
ALCOHOL;
ALKENE;
AMIDE;
ANTIGLAUCOMA AGENT;
CARBON;
CARBOXYLIC ACID;
CHLORINE;
ESTER;
GUANOSINE PHOSPHATE;
HYDROGEN;
PRODRUG;
PROSTAGLANDIN DP RECEPTOR;
PROSTAGLANDIN RECEPTOR;
PROSTAGLANDIN RECEPTOR STIMULATING AGENT;
SILANE DERIVATIVE;
UNCLASSIFIED DRUG;
9-CHLORO-15-CYCLOHEXYL-11,15-DIHYDROXY-3-OXA-16,17,18,19,20-PENTANOR-5-PROSTENOIC ACID;
ANTIHYPERTENSIVE AGENT;
DRUG DERIVATIVE;
PROSTAGLANDIN F2 ALPHA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BINDING AFFINITY;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG EFFECT;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SCREENING;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
INTRAOCULAR HYPERTENSION;
INTRAOCULAR PRESSURE;
NONHUMAN;
OXIDATION;
RECEPTOR AFFINITY;
SPECIES DIFFERENCE;
STEREOCHEMISTRY;
ANIMAL;
CHEMICAL STRUCTURE;
CHEMISTRY;
DRUG POTENTIATION;
GLAUCOMA;
HAPLORHINI;
METABOLISM;
PROTEIN BINDING;
RABBIT;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
TOPICAL DRUG ADMINISTRATION;
ADMINISTRATION, TOPICAL;
ANIMALS;
ANTIHYPERTENSIVE AGENTS;
DINOPROST;
GLAUCOMA;
HAPLORHINI;
INTRAOCULAR PRESSURE;
MOLECULAR STRUCTURE;
PROTEIN BINDING;
RABBITS;
RECEPTORS, PROSTAGLANDIN;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
|
EID: 0036009902
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(02)00016-0 Document Type: Article |
|
Times cited : (22)
|
|
References (44)
|
